medigraphic.com
SPANISH

Cirugía Plástica

ISSN 2992-8559 (Electronic)
ISSN 1405-0625 (Print)
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
    • Send manuscript
  • Policies
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2025, Number 1

<< Back Next >>

Cir Plast 2025; 35 (1)

Abdominal wall reconstruction in incisional hernias: synergy, convergence, and excellence of two surgical disciplines

Reyes-Montero CF, Luna-Madrid EE, Favela-Campos RM, Olivas-Borunda MR, Ballardo-Medina C, Figueroa-Beltrán MV, Gutiérrez-Ramírez M, Almeida-Muñoz DE, Vázquez-Ruiz BA, Camacho MJ
Full text How to cite this article 10.35366/120807

DOI

DOI: 10.35366/120807
URL: https://dx.doi.org/10.35366/120807

Language: Spanish
References: 16
Page: 18-24
PDF size: 388.11 Kb.


Key words:

incisional hernia, botulinum toxin, plastic surgery.

ABSTRACT

The treatment of complex hernias demands a meticulous procedure. As plastic surgeons we must integrate into multidisciplinary teams that handle these conditions. We performed a prospective, longitudinal, and descriptive study of patients with complex incisional hernias managed in a multidisciplinary manner. All patients adhered to the following protocol: infiltration of 100 units of botulinum toxin type A and administration of progressive pneumoperitoneum. All patients had excellent outcomes, with minimal easily managed complications. The maximum hospital discharge time was seven days, even in "giant" defects, averaging 24.8 × 19 cm. In our practice, repairing complex hernias, loss of domain hernias predominates. These deforming and disabling conditions compel us to offer effective therapeutic solutions that facilitate tissue management and restore abdominal wall function. We conclude that abdominal wall reconstruction for complex hernias is a major surgical challenge in modern surgery, which must be addressed by a team, converging surgical expertise from various specialties.


REFERENCES

  1. Hernández C, López M, Morales S, Muysoms F, García J, Pereira J. Profilaxis de la hernia incisional y utilización de mallas. Revisión narrativa. Cir Esp 2018: 76-87.

  2. González A, Rodríguez A, Delgado J, López G, Navarro R. Laparoscopic treatment of incisional hernia with ptfe biological mesh. Cir Parag 2017; 41 (1): 29-32.

  3. Sánchez M, Bazán C, Casado MD, Pérez, D, Bengoechea A, Serrano JL. Hernia primaria-incisional de pared abdominal. Hernias con pérdida de derecho a domicilio. Cir Andal 2013; 24: 270-274.

  4. Espinosa-de-los-Monteros A. La participación de los cirujanos plásticos en las hernias incisionales de la pared abdominal. Rev Hispanoam Hernia 2014; 2 (3): 83-85. Disponible en: http://dx.doi.org/10.1016/j.rehah.2014.03.00

  5. Moreno IG. Chronic eventrations and large hernias; preoperative treatment by progressive pneumoperitomeum; original procedure. Surgery 1947; 22 (6): 945-953.

  6. Ibarra HTR. Botulinum toxin type A: its importance in patients with large abdominal hernias. 2014; 2 (4): 131-132.

  7. Carbonell TF, Moreno EA. Eventraciones. Valencia: Los autores, 2012, pp. 357-390.

  8. Jacob B, Ramshaw B. The SAGES manual of hernia repair. 3rd ed. New York, NY: Springer New York, 2019, pp. 146-160.

  9. Liang MK, Goodenough CJ, Martindale RG, Roth JS, Kao LS. External validation of the ventral hernia risk score for prediction of surgical site infections. Surg Infect (Larchmt). 2015; 16 (1): 36-40.

  10. Saleh S, Plymale MA, Davenport DL, Roth JS. Risk-assessment score and patient optimization as cost predictors for ventral hernia repair. J Am Coll Surg 2018; 226 (4): 540-546.

  11. Parker SG, Halligan S, Liang MK, Muysoms FE, Adrales GL, Boutall A et al. Definitions for loss of domain: An international Delphi consensus of expert surgeons. World J Surg 2020; 44 (4): 1070-1078. Available in: http://dx.doi.org/10.1007/s00268-019-05317-z

  12. Tang FX, Ma N, Huang E, Ma T, Liu CX, Chen S et al. Botulinum toxin A facilitated laparoscopic repair of complex ventral hernia. Front Surg 2022; 8: 803023. Available in: http://dx.doi.org/10.3389/fsurg.2021.803023

  13. Bueno-Lledó J, Carreño-Saenz O, Torregrosa-Gallud A, Pous-Serrano S. Preoperative botulinum toxin and progressive pneumoperitoneum in loss of domain hernias-our first 100 cases. Front Surg 2020; 7: 3. Available in: http://dx.doi.org/10.3389/fsurg.2020.00003

  14. Whitehead-Clarke T, Windsor A. The use of botulinum toxin in complex hernia surgery: achieving a sense of closure. Front Surg 2021; 8: 753889. Available in: http://dx.doi.org/10.3389/fsurg.2021.753889

  15. Timmer AS, Claessen JJM, Atema JJ, Rutten MVH, Hompes R, Boermeester MA. A systematic review and meta-analysis of technical aspects and clinical outcomes of botulinum toxin prior to abdominal wall reconstruction. Hernia 2021; 25 (6): 1413-1425. Available in: http://dx.doi.org/10.1007/s10029-021-02499-1

  16. Sánchez M, Marenco de la Cuadra B, Retamar M, Cano A, López JA. Hernias con derecho a domicilio. Revisión de los últimos 5 años. Cir Andal 2018; 29 (2): 94-99.




Figure 1
Figure 2
Figure 3
Table 1

2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Cir Plast. 2025;35